Characterization of chromosomal abnormalities in prostate cancer cell lines by spectral karyotyping

被引:49
作者
Pan, Y [1 ]
Kytölä, S
Farnebo, F
Wang, N
Lui, WO
Nupponen, N
Isola, J
Visakorpi, T
Bergerheim, USR
Larsson, C
机构
[1] Karolinska Hosp, Res Ctr M300, Res Lab Urol, Dept Urol, S-17176 Stockholm, Sweden
[2] Karolinska Hosp, Dept Mol Med, CMM, S-17176 Stockholm, Sweden
[3] Karolinska Hosp, Dept Med Radiobiol, S-17176 Stockholm, Sweden
[4] Univ Tampere, Inst Med Technol, Canc Genet Lab, FIN-33101 Tampere, Finland
[5] Tampere Univ Hosp, Tampere, Finland
来源
CYTOGENETICS AND CELL GENETICS | 1999年 / 87卷 / 3-4期
关键词
D O I
10.1159/000015432
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Human prostate cancer is characterized by multiple gross chromosome alterations involving several chromosome regions. However, the specific genes involved in the development of prostate tumors are still largely unknown. Here we have studied the chromosome composition of the three established prostate cancer cell lines, LNCaP, PC-3, and DU145, by spectral karyotyping (SKY). SKY analysis showed complex karyotypes for all three cell lines, with 87, 58/113, and 62 chromosomes, respectively. All cell lines were shown to carry structural alterations of chromosomes 1, 2, 4, 6, 10, 15, and 16; however, no recurrent breakpoints were detected. Compared to previously published findings on these cell lines using comparative genomic hybridization, SKY revealed several balanced translocations and pinpointed rearrangement breakpoints. The SKY analysis was validated by fluorescence in situ hybridization using chromosome-specific, as well as locus-specific, probes. Identification of chromosome alterations in these cell lines by SKY may prove to be helpful in attempts to clone the genes involved in prostate cancer tumorigenesis. Copyright (C) 2000 S. Karger AG, Basel.
引用
收藏
页码:225 / 232
页数:8
相关论文
共 40 条
[1]   DELETION MAPPING OF CHROMOSOME-8, CHROMOSOME-10, AND CHROMOSOME-16 IN HUMAN PROSTATIC-CARCINOMA [J].
BERGERHEIM, USR ;
KUNIMI, K ;
COLLINS, VP ;
EKMAN, P .
GENES CHROMOSOMES & CANCER, 1991, 3 (03) :215-220
[2]  
Brothman AR, 1999, PROSTATE, V38, P303
[3]   ALLELIC LOSS OF CHROMOSOME-16Q AND CHROMOSOME-10Q IN HUMAN PROSTATE-CANCER [J].
CARTER, BS ;
EWING, CM ;
WARD, WS ;
TREIGER, BF ;
AALDERS, TW ;
SCHALKEN, JA ;
EPSTEIN, JI ;
ISAACS, WB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (22) :8751-8755
[4]  
Cher ML, 1996, CANCER RES, V56, P3091
[5]   MUTATION OF THE MXI1 GENE IN PROSTATE-CANCER [J].
EAGLE, LR ;
YIN, XY ;
BROTHMAN, AR ;
WILLIAMS, BJ ;
ATKIN, NB ;
PROCHOWNIK, EV .
NATURE GENETICS, 1995, 9 (03) :249-255
[6]   Specific chromosomal aberrations and amplification of the AIB1 nuclear receptor coactivator gene in pancreatic carcinomas [J].
Ghadimi, BM ;
Schröck, E ;
Walker, RL ;
Wangsa, D ;
Jauho, A ;
Meltzer, PS ;
Ried, T .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (02) :525-536
[7]   A HIGH-RESOLUTION STUDY OF CHROMOSOME CHANGES IN A HUMAN PROSTATIC-CARCINOMA CELL-LINE (LNCAP) [J].
GIBAS, Z ;
BECHER, R ;
KAWINSKI, E ;
SANDBERG, AA ;
HOROSZEWICZ, J .
CANCER GENETICS AND CYTOGENETICS, 1984, 11 (04) :399-404
[8]  
Horoszewicz JS, 1980, MODELS PROSTATE CANC, P115
[9]  
Isaacs WB, 1995, CANCER SURV, V25, P357
[10]  
ISCN, 1995, INT SYST HUM CYT NOM